Login
$ELMD
$27.28 +$0.62 (2.33%) Close

Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2026
As of Jun 30, 2026
Q3 FY2026
As of Mar 31, 2026
Q2 FY2026
As of Dec 31, 2025
Q1 FY2026
As of Sep 30, 2025
Q4 FY2025
As of Jun 30, 2025
Q3 FY2025
As of Mar 31, 2025
Q2 FY2025
As of Dec 31, 2024
Q1 FY2025
As of Sep 30, 2024
Q4 FY2024
As of Jun 30, 2024
Q3 FY2024
As of Mar 31, 2024
Q2 FY2024
As of Dec 31, 2023
Q1 FY2024
As of Sep 30, 2023
Q4 FY2023
As of Jun 30, 2023
Q3 FY2023
As of Mar 31, 2023
Q2 FY2023
As of Dec 31, 2022
Q1 FY2023
As of Sep 30, 2022
Q4 FY2022
As of Jun 30, 2022
Q3 FY2022
As of Mar 31, 2022
Q2 FY2022
As of Dec 31, 2021
Q1 FY2022
As of Sep 30, 2021
Current Assets
Cash and cash equivalents
Accounts receivable (net of allowances for credit losses of $45,000)
Contract assets
Inventories
Prepaid expenses and other current assets
Income tax receivable
Total current assets
Net property and equipment
Finite-life intangible assets, net
Other Assets, Noncurrent
Deferred income taxes
Total assets
Current Liabilities
Accounts payable
Accrued compensation
Income tax payable
Other accrued liabilities
Warranty reserve
Other Accrued Liabilities, Current
Total current liabilities
Other long-term liabilities
Total liabilities
Shareholders’ Equity
Common stock, $0.01 par value per share, 13,000,000 shares authorized; 8,366,163 and 8,349,176 shares issued and outstanding, as of June 30, 2026, and June 30, 2025, respectively
Additional paid-in capital
Retained earnings
Total shareholders’ equity
Total liabilities and shareholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support